Literature DB >> 12160643

Haplotype exclusion: the solution to a problem in natural selection.

Rodney Langman1, Melvin Cohn.   

Abstract

Antibody that possesses two identical paratopes (bivalent) is aggregated by antigen to trigger effector function. Antibody that possesses two different paratopes behaves as functionally monovalent. If these two antibodies interact with a given epitope, the monovalent antibody will block the aggregation of the bivalent antibody thereby inhibiting effector activation. We advance the hypothesis that haplotype exclusion is driven by the necessity to reduce the level of monovalent antibody. This assumption is compared to previous suggestions and quantitated. Further, several mechanisms of haplotype exclusion used by various species are analyzed in the light of this hypothesis.

Mesh:

Year:  2002        PMID: 12160643     DOI: 10.1016/s1044-5323(02)00039-8

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  4 in total

Review 1.  A stepwise model of polyreactivity of the T cell antigen-receptor (TCR): its impact on the self-nonself discrimination and on related observations (receptor editing, anergy, dual receptor cells).

Authors:  Melvin Cohn
Journal:  Cell Mol Life Sci       Date:  2013-12-14       Impact factor: 9.261

2.  A hypothesis accounting for the paradoxical expression of the D gene segment in the BCR and the TCR.

Authors:  Melvin Cohn
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

3.  Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice.

Authors:  Emilie M Fournier; Maria-Gabriela Velez; Katelyn Leahy; Cristina L Swanson; Anatoly V Rubtsov; Raul M Torres; Roberta Pelanda
Journal:  J Exp Med       Date:  2012-08-27       Impact factor: 14.307

4.  Editing anti-DNA B cells by Vlambdax.

Authors:  Yijin Li; Yoram Louzoun; Martin Weigert
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.